Euroopa Liit - eesti - EMA (European Medicines Agency)

roche registration gmbh  - glofitamab - lymphoma, large b-cell, diffuse - antineoplastilised ained - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.

Eesti - eesti - Adama

adama - vees dispergeeruvad graanulid - kaptaan - fungitsiidid

Euroopa Liit - eesti - EMA (European Medicines Agency)

janssen-cilag international n.v. - teclistamab - mitu müeloomit - antineoplastilised ained - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Eesti - eesti - Ravimiamet

linde gas ab - hapnik - meditsiiniline surugaas - 100% 50l 10tk; 100% 5l 1tk; 100% 15l 1tk; 100% 20l 1tk; 100% 2l 1tk; 100% 4l 1tk; 100% 1.2l 1tk; 100% 2l 2tk; 100% 21.3l 2tk; 100% 1l 1tk; 100% 1.1l 1tk; 100% 50l 12tk; 100% 3l 1tk; 100% 21.3l 1tk; 100% 10l 1tk

Eesti - eesti - Ravimiamet

linde gas ab - hapnik - krüogeenne meditsiiniline gaas - 100% 31l 1tk; 100% 12l 1tk; 100% 45l 1tk; 100% 55l 1tk; 100% 600l 1tk; 100% 10l 1tk; 100% 20l 1tk; 100% 36l 1tk; 100% 26l 1tk; 100% 21l 1tk; 100% 40l 1tk; 100% 37l 1tk; 100% 41l 1tk